(412) 586-4678
(412) 586-4678
"I use CBD Pain Balm on my knees - when I don’t use it, I notice my knees and joints feels achy. Magnesium helps me sleep and stay on track. CBD Oil helps me sleep - 8 hours at night!"
- V. L.
A smooth and spreadable (unscented) balm applied topically to painful areas like arthritic joints and painful damaged nerve areas. Massage in well as often as needed. Heat the area for a few minutes first for enhanced absorption.
Broad Spectrum PCR – Phytocannabinoid Rich Plant Oil with CBD and other minor phytocannabinoids such as cannabigerol – CBG, cannabinol – CBN, and cannabichromene – CBC, and over 40 naturally present synergistic terpenes.
We are proud to introduce our new and improved Nano CBD Pain Cream - a game changer in CBD therapy!
Our pharmacist and owner Susan M. is on the cutting edge of innovatiove technology and we are compounding these incredible capsules on site in our lab.
NEW Nano CBD Hemp Pain Cream is now 33.33 mg CBD/application at 99% absorption—> 33.0 mg absorbed!
Old 1000mg/jar=20mg CBD/application.At 15% absorption—>3mg/application absorbed
**Massage in well for 1-2 minutes. Contains fine crystals that dissolve with massage for enhanced absorption and fast relief. No residue. It provides relief and skin moisturizing at the same time, making it perfect for dry, rough, painful burning feet from Neuropathy, standing for long hours, or to smooth the feet; in addition to arthritic joints and stiff muscles (restless leg).
*Remember absorption in general is based on the size of the individual and the amount of body fat for topical application. The body fat prevents absorption, so heavier individuals may need to apply more often as well as using oral Nano CBD Hemp Capsules in addition to the Nano CBD Pain Cream for better effect. It is important to know your goals of therapy, how long the condition has been present, and your other medications when choosing a CBD product.
Water-soluble products are better absorbed than oil-based products. -Raj Gupta PhD CBD scientist.
General CBD Serving Guidelines: Start LOW & Go SLOW!
Less is more! By starting low and slowly increasing until you find your personal balance or homeostasis, you may get optimal benefits without wasting money on excess CBD.
Everyone is different and everyone’s internal balance system (Homeostasis) is different. Some people are slightly “out of balance” and other people are very much “out of balance.” Some people are very sensitive to substances and others are less responsive. There is no magic number, no formula, and no test to determine how “out of balance” you are. The good news is we have a great method to discover your “happy place” or “optimal serving.” We call this process “micro-servings.”
Please Note: The amount of body fat, duration and severity of condition, GI/Liver function, individual biochemical makeup, and endocannabinoid balance may affect outcome.
ATTENTION: Some medications may interact or impact serving size. Please call 412-586-4678 to speak to a Pharmacist or assisatnt about any medications you are taking.
Potential Minimal Side Effects: Dry mouth, low blood pressure, lightheadedness, potential feelings similar to dizziness and fatigue. - Source: https://medlineplus.gov/druginfo/natural/1439.html
Safety Concerns: Cannabidiol doses of up to 300 mg daily have been taken by mouth safely for up to 6 months. Higher doses of 1200-1500 mg daily have been taken by mouth safely for up to 4 weeks. – Source: https://medlineplus.gov/druginfo/natural/1439.html
NOTE: Many people feel more mentally alert and focused using CBD so we suggest starting the initial serving in the AM for at least a week before adding a second PM serving.
Help us further CBD Research! Fill out our questionnaire and help us collect important data about CBD and your experience! Click here to fill out our CBD Questionnaire.
Not recommended for use in pregnant women or women who are breastfeeding as there is not enough reliable information on these groups. Please consult your physician before use.
For more information on CBD please consult the following paper from the National Institutes of Health: PACHER P, BÁTKAI S, KUNOS G. The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological reviews. 2006;58(3):389-462. doi:10.1124/pr.58.3.2.
And the World Health Organization’s paper, “CANNABIDIOL (CBD) Pre-Review Report Agenda Item 5.2 Expert Committee on Drug Dependence, Thirty-ninth Meeting, Geneva, 6-10 November 2017.
Another useful resource is the National Institutes of Health’s US National Library of Medicine, https://medlineplus.gov/druginfo/natural/1439.html
